Defining Cure Through Targeted Therapeutics
We are a next-generation biotech company dedicated to transforming the lives of patients through precision RNA medicine and collaborative science.
Watch Video
Transforming Lives Through RNA Science
AlterRNA is dedicated to developing next-generation RNA therapeutics that address the underlying genetic causes of disease. Our platform technology enables precise modification of RNA to restore normal protein function.
Precision Medicine
Precisely targeting specific genetic mutations
Innovation
Pioneering novel RNA modification technologies
Patient-Centric
Driven by the needs of patients and their families
Scientific Excellence
Committed to rigorous research and development
$50M+
Funding Raised
100+
Team Members
25+
Publications
10+
Patents Filed
Addressing Critical Unmet Needs
Our pipeline targets rare genetic diseases across multiple therapeutic areas, bringing hope to patients with limited treatment options.
Neurology
Rare genetic neurological disorders
Cardiology
Inherited cardiovascular conditions
Ophthalmology
Genetic retinal diseases
Hematology
Blood and immune disorders
Metabolic
Inherited metabolic diseases
Development Pipeline
AlterRNA is dedicated to developing next-generation RNA therapeutics
Delivery Candidate Systems By Vicky tssdw
This project is related to delivery 77878
Human BBB Platform (Organ-Specific Delivery)
This research is for Human BBB platform for organ specific…
MPAN-C19orf12 Therapeutics Master
Novel approach to treating lysosomal storage diseases through targeted mRNA…
Collaborative Knowledge Exchange
Join our secure network of researchers, clinicians, and partners to share insights, discuss methodologies, and advance the field of RNA therapeutics together.
Invest in the Future of Bio-Medicine
AlterRNA offers unique opportunities for investors to fund high-potential therapeutic projects with full transparency and data-backed milestones.
$450M+
Research Funded
12
Clinical Stage Assets
85+
Partner Institutions
2.4X
Yearly Growth